Conti Carlo / Herzfeld Adam / Künzler Oliver / Mayoraz Jean-François / Müller Melanie

The Pharma Legal Handbook Switzerland

30.03.20

Regulatory, Pricing and Reimbursement Overview · Preclinical and Clinical Trial Requirements · Marketing, Manufacturing, Packaging and Labeling Advertising · Traditional Medicines and OTC Products · Product Liability · Patents and Trademarks · Regulatory Reforms | Pharma Board Room, London 2020

Braun Martina / Conti Carlo / Künzler Oliver

GLI - Pricing & Reimbursement 2019

02.10.19

Every resident in Switzerland is mandatorily obliged to be covered by basic healthcare insurance which provides for a wide range of services. Persons with lower incomes are, in principle, granted reductions on the premiums payable for such basic healthcare insurance. Thus, every resident in Switzerland is granted access to affordable healthcare. In general, therapeutic products are only reimbursed if they are listed on the so-called specialty list. In order to be listed thereon, a medicinal product must be admitted by the competent Swiss authority, and has to satisfy the criteria of effectiveness, functionality and economic efficiency, based on which the maximum price for the therapeutic product in question is determined.

Müller Melanie

Aktuelle Entwicklungen im Bereich Life Sciences

02.10.19

Tagungsbericht zum Seminar des Europa Instituts an der Universität Zürich vom 2. Oktober 2018 in Zürich, in Life Science Recht (LSR) 1/2019, S. 53-59

Braun Martina / Conti Carlo / Künzler Oliver

GLI – Pricing & Reimbursement 2018

31.05.18

Every resident in Switzerland is mandatorily obliged to be covered by basic healthcare insurance which provides for a wide range of services. Persons with lower incomes are in principle granted reductions on the premiums payable for such basic healthcare insurance. Thus, every resident in Switzerland is granted access to affordable healthcare.

Braun Martina

Totalrevision des GUMG

12.02.18

In: LES Newsletter 1-18, Zürich 2018

International Conference: Innovation and Competition in Life Sciences Law, Conference held by Law Faculty of the University of Basel on June 9, 2017 in Basel

03.11.17

In: Life Science Recht 1/2018, S. 65f. (zusammen mit Dr. Andreas Schöllhorn)

Künzler Oliver

The life sciences, drugs and healthcare industry in 2016 and beyond: trends and predictions

16.06.16

Edited by Thomson Reuters, Practical Law, London (June 2016)

Braun Martina / Künzler Oliver

Challenges and key aspects of life sciences M&A in Switzerland

26.04.16

In: Thomson Reuters, Practical Law, Global Life Sciences Guide 2016/2017

Braun Martina / Künzler Oliver

Challenges and key aspects of life sciences M&A in Switzerland

01.06.15

In: Thomson Reuters, Practical Law, Global Life Sciences Guide 2015/2016 | Private M&A Guide 2015/2016

Braun Martina / Künzler Oliver

Challenges and key aspects of life sciences M&A in Switzerland

26.04.15

In: Thomson Reuters, Practical Law, Global Life Sciences Guide 2015/2016 | Private M&A Guide 2015/2016